Patients and plans both benefit from better medication access, affordability and adherence. Cash pharmacies and discount cards—in tandem with the pharmacy benefit—can help improve all three.
The pandemic brought an uptick in prescription deliveries, yet they still lag behind most other online purchases. Here’s why that is bound to change.
Up to 10 competing products for Humira are on the way in 2023. What should health plans and plan sponsors be following as the biosimilars landscape takes shape?
A wave of FDA-approved biosimilars for Humira and other costly biologics will enter the U.S. market in 2023. What does it mean for patients, payers and plan designs?
Seemingly since the beginning of time, consumers have rarely known what a doctor visit, medical procedure or medication will cost until it’s time to pay. Fortunately, things are starting to change.
The only people who can write prescriptions typically have no idea what patients will pay at the pharmacy. It’s time to solve this problem.
A widely prescribed acid reflux medication now has an authorized generic available. Good news, but five low-cost proton-pump inhibitor (PPIs) generics often work just as well.
January produced another price hike party from drug makers. But some data indicate prescription prices are actually falling. For consumers? Same as it ever was, or worse.
A $100 gift may not go as far as it once did, but the only inflation this holiday season was in the hearts of hundreds of RxSS employees and clients who gave their gifts to others.
